Chronic prostatitis can be a frustrating, long-lasting condition that affects pelvic comfort, urinary symptoms and sexual wellbeing. For some men, symptoms continue despite antibiotics, anti-inflammatories, pelvic floor therapy or lifestyle changes. Low-intensity extracorporeal shock wave therapy (ESWT) is a non-surgical, drug-free option that may help reduce pain and improve quality of life in selected patients, particularly when symptoms are driven by chronic pelvic pain and muscle tension rather than ongoing infection.

Understanding chronic prostatitis and chronic pelvic pain syndrome

The term “prostatitis” is often used broadly. In practice, many men with long-term symptoms have chronic prostatitis or chronic pelvic pain syndrome (CP/CPPS). This is usually not caused by an active bacterial infection, even though symptoms can feel similar to a urinary infection.

Common symptoms can include:

• Pain or discomfort in the perineum (between the scrotum and anus), lower abdomen, penis, testicles or lower back
• Burning or discomfort when passing urine
• Urinary frequency, urgency, or a weak stream
• Pain with ejaculation, reduced sexual confidence, or erectile difficulties
• Symptoms that fluctuate over time and worsen with stress, prolonged sitting, cycling, constipation, or certain foods and drinks

Because CP/CPPS can have multiple contributing factors (pelvic floor muscle overactivity, nerve sensitisation, inflammation, bladder involvement, and psychological stress), treatment often works best as a structured plan rather than a single intervention.

What ESWT is and what it aims to do

Extracorporeal shock wave therapy uses low-intensity acoustic waves delivered through the skin to targeted areas. In chronic prostatitis and CP/CPPS, ESWT is used with the aim of:

• Reducing pelvic pain by modulating pain signalling pathways
• Improving local blood flow and tissue healing responses
• Helping relax overactive pelvic floor muscles and reduce trigger-point sensitivity
• Supporting improvements in urinary symptoms and sexual function in some patients

ESWT for chronic prostatitis is not the same as the higher-energy shock wave treatment used to break kidney stones. The intensity used for pelvic pain conditions is lower and is designed to be well tolerated.

Who may benefit, and when it may not be the right option

ESWT may be considered for men who:

• Have symptoms lasting at least 3 months, consistent with CP/CPPS
• Have persistent pelvic pain despite initial treatments (for example anti-inflammatories, alpha-blockers, pelvic floor physiotherapy, or neuropathic pain medicines)
• Have no evidence of an active urinary tract infection on appropriate testing
• Prefer a non-surgical approach and want to minimise long-term medication use

It may be less suitable, or require careful planning, if:

• There is suspected or confirmed acute bacterial prostatitis (fever, chills, significant systemic illness), which needs urgent medical treatment
• There is ongoing infection that has not been fully assessed
• Symptoms are primarily due to another condition such as bladder cancer, urethral stricture, significant benign prostate enlargement, or a neurological bladder problem
• There is a bleeding disorder or use of certain blood-thinning medicines, depending on individual risk
• There is severe pain requiring urgent assessment, blood in urine, unexplained weight loss, or new testicular lumps

A clear diagnosis matters. ESWT is best used when the clinical picture fits chronic pelvic pain rather than infection.

Assessment and planning before treatment

Before starting ESWT, an assessment at our specialist urology and sexual health clinic focuses on confirming the diagnosis and identifying contributing factors that can be treated alongside ESWT.

This typically includes:

• A detailed symptom history, including pain pattern, urinary symptoms, sexual symptoms and triggers
• Review of previous urine tests, cultures, STI testing and any prior antibiotic courses
• Physical examination, which may include abdominal, genital and pelvic floor assessment; a prostate examination may be recommended in some cases
• Urine testing and, when appropriate, additional tests such as uroflowmetry, ultrasound, or blood tests
• Use of validated symptom questionnaires (often used in prostatitis care) to track progress over time

If there are red flags or uncertainty about the diagnosis, further investigations may be advised before proceeding.

What the treatment sessions are like

ESWT is carried out in an outpatient setting and does not require anaesthetic. A handheld applicator delivers low-intensity acoustic pulses to specific areas associated with pelvic pain.

A typical appointment involves:

• Positioning for comfort and privacy
• Application of gel to help transmit the acoustic waves
• Delivery of pulses to targeted regions (commonly the perineal area, and sometimes additional pelvic pain points depending on symptoms and examination findings)

Most men describe the sensation as tapping or mild discomfort rather than pain. The intensity can be adjusted to keep treatment tolerable.

How many sessions are usually needed?

Protocols vary, but a course is commonly delivered over several sessions across a few weeks. The exact number and frequency are tailored to symptom severity, duration, and response.

ESWT is often used as part of a broader plan. Where pelvic floor overactivity is a major driver, combining ESWT with pelvic floor physiotherapy and relaxation strategies may improve outcomes.

What to expect after ESWT

There is usually no downtime. Most patients return to normal activities the same day.

Symptom change is typically gradual. Some men notice improvement after a few sessions, while others see benefits later, often over several weeks. Improvements may include reduced pain intensity, fewer flare-ups, and better urinary comfort. Sexual symptoms may also improve in some patients, particularly when pain reduction leads to better confidence and less pelvic muscle tension.

Follow-up is important. Progress is usually monitored using symptom scores and a structured review so the plan can be adjusted if needed.

Risks, side effects and limitations

ESWT for CP/CPPS is generally considered low risk when appropriately selected and delivered.

Possible side effects are usually mild and temporary, such as:

• Local tenderness during or after treatment
• Temporary redness or sensitivity of the treated skin
• A short-lived increase in symptoms (a flare) in a small number of patients

Limitations to understand:

• Not every case responds. CP/CPPS is complex, and outcomes vary.
• ESWT does not treat an active bacterial infection.
• If symptoms are driven by another diagnosis (for example significant prostate enlargement, bladder pathology, or urethral narrowing), ESWT alone is unlikely to be sufficient.
• Long-term symptom control often depends on addressing contributing factors such as pelvic floor tension, bowel habits, stress, sleep, and physical activity.

Your clinician will discuss realistic expectations and how success will be measured for you, such as pain reduction, improved daily function, and fewer flare-ups.

How our medical team supports you throughout

Care for chronic prostatitis is most effective when it is coordinated and consistent. At our specialist urology and sexual health clinic, you are supported by a medical team that focuses on:

• Confirming the diagnosis and ruling out important alternative causes
• Building a personalised plan that may include ESWT alongside medication review, pelvic floor physiotherapy, lifestyle guidance and sexual health support
• Monitoring progress with structured follow-up and adjusting the plan if symptoms change
• Providing clear advice on flare management and when to seek urgent review

If you are considering ESWT, the first step is a consultation to ensure the treatment matches your diagnosis and goals, and that any necessary tests are completed before starting.